Successful Drug Trial Results for Light Intolerant ‘Shadow Jumpers’

Published July 14, 2010

Successful Drug Trial Results for Light Intolerant ‘Shadow Jumpers’
MELBOURNE, Australia—-A new Australian drug has been shown to assist in protecting patients with a rare genetic disorder that makes their skin toxic to light and UV, and previously forced them to live in the shadows.
Read more on Business Wire via Yahoo! Finance

ChemGenex surges on FDA nod for cancer drug
Shares in ChemGenex Pharmaceuticals surged after it announced a breakthrough with the US Food and Drug Administration (FDA) regarding the approval of a new cancer drug.
Read more on thewest.com.au

Arrests in suspected drug house explosion
Two local men have been charged in connection with the explosion last month at a suspected drug house.
Read more on Toronto Sun